secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0000950170-23-016427
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q1 net rev $491M, GAAP EPS $0.17, adj EPS $0.23, reaffirms FY adj EBITDA $235-245M
--------------------------------------------------------------------------------

- Net revenue $491M, up 1.8% YoY; same-unit revenue up 2.0% driven by volume and collections.
- GAAP EPS $0.17; adjusted EPS $0.23; prior year adjusted EPS $0.33 (incl $0.07 CARES benefit).
- Adjusted EBITDA $40.1M vs $50.7M YoY; FY 2023 guidance reaffirmed at $235-245M.
- Cash used in ops $100.6M; total debt $752M; share count decreased due to 2022 buybacks.
- No CARES Act revenue recorded in Q1 2023 vs $10.4M in Q1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017023016427/0000950170-23-016427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017023016427/md-20230502.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-016427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer